BioStem Technologies, Inc. (BSEM) Misses Q1 EPS by 24c
Tweet
Share
E-mailGet Alerts BSEM Hot Sheet
Join SI Premium – FREE
BioStem Technologies, Inc. (OTC: BSEM) reported Q1 EPS of $0.27, $0.24 worse than the analyst estimate of $0.51. Revenue for the quarter came in at $72.53 million versus the consensus estimate of $82.5 million.
For earnings history and earnings-related data on BioStem Technologies, Inc. (BSEM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA Committee Recommends To Widen Access To Bpc-157 Peptide
- Towne Bank (TOWN) Misses Q2 EPS by 1c
- Origin Bancorp, Inc. (OBK) Tops Q2 EPS by 9c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
